Benzoquinone

Benzoquinone

SCHEMBL3208089

O=C1C=CC(=O)C=C1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoquinone SCHEMBL460082 1.00 ALDH1A1 (1.00)
Benzoquinone SCHEMBL30679171 1.00
Benzoquinone SCHEMBL10506648 1.00 ALDH1A1 (1.00)
Benzoquinone SCHEMBL18103 1.00
Benzoquinone SCHEMBL5308519 1.00 ALDH1A1 (1.00)
Benzoquinone SCHEMBL3394588 0.94
Benzoquinone SCHEMBL4207161 0.94 ALDH1A1 (0.89)
Benzoquinone SCHEMBL1873085 0.94
Benzoquinone SCHEMBL6846712 0.94
Benzoquinone SCHEMBL3235600 0.94 ALDH1A1 (0.89)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115054608-A Application of cryptotanshinone substances and combination composition thereof 澳门大学 2022-09-16 CN claimed
US-20240180937-A1 CYTOKINE PRODUCTION SUPPRESSING COMPOSITION CONTAINING D-ALLOSE AS ACTIVE COMPONENT, AND METHOD OF TREATING OR PREVENTING DISEASE ASSOCIATED WITH CYTOKINE OVERPRODUCTION USING SAME NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) 2024-06-06 US disclosed
WO-2023190568-A1 OSMOTIC PRESSURE REGULATING AGENT AND METHOD FOR REGULATING OSMOTIC PRESSURE 国立大学法人 香川大学 2023-10-05 WO disclosed
WO-2023136329-A1 CELL PROLIFERATION RETARDANT, COSMETIC CONTAINING SAME, AND CELL PROLIFERATION RETARDATION METHOD 国立大学法人 香川大学 2023-07-20 WO disclosed
US-20230141777-A1 COMPOSITION WHICH IS FOR TREATING OR PREVENTING RENAL CELL CANCER AND CONTAINS D-ALLOSE AS ACTIVE INGREDIENT, AND METHOD FOR TREATING OR PREVENTING CANCER USING SAME SETOLAS HOLDINGS, INC. (JP) 2023-05-11 US disclosed
EP-4159219-A1 COMPOSITION WHICH IS FOR TREATING OR PREVENTING RENAL CELL CANCER AND CONTAINS D-ALLOSE AS ACTIVE INGREDIENT, AND METHOD FOR TREATING OR PREVENTING CANCER USING SAME National University Corporation Kagawa University (JP) 2023-04-05 EP disclosed
CN-115335061-A Composition for treating or preventing renal cell carcinoma comprising D-allose as an active ingredient, and method for treating or preventing cancer using the same 国立大学法人香川大学 2022-11-11 CN disclosed
EP-1854796-B1 OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF AND METHOD FOR PRODUCING SAME NIPPON SODA CO (JP) 2016-05-04 EP disclosed
US-8962898-B2 Optically active ammonium salt compound, production intermediate thereof, and production method thereof NIPPON SODA CO., LTD. (JP) 2015-02-24 US disclosed
CN-101146812-B Optically active ammonium salt compound, intermediate for production thereof, and process for production thereof NIPPON SODA CO 2013-10-16 CN disclosed
US-8367820-B2 Optically active ammonium salt compound, production intermediate thereof, and production method thereof NIPPON SODA CO., LTD. (JP) 2013-02-05 US disclosed
US-20100041881-A1 OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF, AND PRODUCTION METHOD THEREOF NIPPON SODA CO., LTD. (JP) 2010-02-18 US disclosed
CN-101146812-A Optically active ammonium salt compound, intermediate for production thereof, and process for production thereof UNIV KYOTO (JP) 2008-03-19 CN disclosed
US-20080051598-A1 Process for Production of Polysubstituted Cyclobutanes and Polysubstituted Cyclobutenes NATIONAL UNIVERSITY CORPORATION TOHOKU UNIVERSITY (JP) 2008-02-28 US disclosed
EP-1854796-A1 OPTICALLY ACTIVE AMMONIUM SALT COMPOUND, PRODUCTION INTERMEDIATE THEREOF AND METHOD FOR PRODUCING SAME Kyoto University (JP) 2007-11-14 EP disclosed
EP-1775300-A1 PROCESS FOR PRODUCTION OF POLYSUBSTITUTED CYCLOBUTANES AND POLYSUBSTITUTED CYCLOBUTENES National University Corporation Tohoku Unversity (JP) 2007-04-18 EP disclosed
CN-1178900-C Anti-tumour agents 2004-12-08 CN disclosed
CN-1293654-A Antitumor agent ASTRA ZENECA LTD (SE) 2001-05-02 CN disclosed
CN-1293656-A Anti-tumour agents ASTRA ZENECA BRITISH LTD (GB) 2001-05-02 CN disclosed
EP-0334362-A2 Heat developable color light-sensitive material Fuji Photo Film Co., Ltd. (JP) 1989-09-27 EP disclosed